Biotech

All Articles

ReNeuron leaving AIM exchange after skipping fundraising goal

.ReNeuron has joined the long listing of biotechs to leave London's AIM securities market. The stem ...

MBX declare IPO to take opposition to Ascendis into period 3

.MBX Biosciences has actually added to the latest outbreak of IPO filings. The biotech, which submit...

FDA increases probe in to Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and also the company's would-be MDMA-assisted treatment for post-traumatic s...

Gene publisher Tome giving up 131 workers

.Merely times after gene publisher Volume Biosciences revealed secret functional slices, a clearer p...

Repare lays off 25% of team as biotech stops preclinical R&ampD

.Repare Therapy is giving up a quarter of its workforce as the oncology biotech lessen its own precl...

J &amp J apply for FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has taken one more action toward realizing a profit on its $6.5 billion nipoca...

Gain's period 1 win paves method to show Parkinson's medication's worth

.Gain Therapies has specified its direct showing the efficiency of its own Parkinson's illness treat...

Actinogen files new phase 2 records to recover anxiety drug

.Actinogen Medical's hopes-- and sell price-- have recoiled somewhat from previously this month, whe...

Pfizer and also Main incorporate Ratio to multibillion-dollar equation

.Flagship Pioneering and also Pfizer have added Quotient right into their 10-program relationship, i...

Bayer pens $547M contract to press boundaries of noncoding RNA

.Bayer execs were actually eager to anxiety to Intense this summer months that the German pharma gia...